设为首页加入收藏
  • 首页
  • Start up
  • 当前位置:首页 >Start up >【】

    【】

    发布时间:2025-09-12 20:55:59 来源:都市天下脉观察 作者:Start up

    Latest

    AI

    Amazon

    Apps

    Biotech & Health

    Climate

    Cloud Computing

    Commerce

    Crypto

    Enterprise

    EVs

    Fintech

    Fundraising

    Gadgets

    Gaming

    Google

    Government & Policy

    Hardware

    Instagram

    Layoffs

    Media & Entertainment

    Meta

    Microsoft

    Privacy

    Robotics

    Security

    Social

    Space

    Startups

    TikTok

    Transportation

    Venture

    More from TechCrunch

    Staff

    Events

    Startup Battlefield

    StrictlyVC

    Newsletters

    Podcasts

    Videos

    Partner Content

    TechCrunch Brand Studio

    Crunchboard

    Contact Us

    Molecule models of the calcium-binding protein calmodulin (CaM). This protein is found in all eukaryotic cells, where it regulates and modifies the activities of many calcium-binding enzymes. Cellular processes that CaM affects include muscle contraction, inflammation, immune response and memory.
    Image Credits:JUAN GAERTNER/SCIENCE PHOTO LIBRARY / Getty Images
    Startups

    A first look at nine new IndieBio NY companies that will present to VCs next month

    Connie Loizos 6:11 PM PST · December 22, 2023

    It was pure coincidence, but months before the pandemic took hold around the world, IndieBio — a startup accelerator devoted to startups using biology to solve large problems — expanded its remit, adding a New York arm to the operations it was already running out of San Francisco. Of course, it’s because of what the world endured that more attention than ever is being paid to life sciences startups, which is why we thought readers might want a sneak peek at the newest batch of startups that IndieBio NY is preparing to introduce to investors in roughly one month.

    If you’re a founder or VC or simply an interested industry observer looking for insights into what’s bubbling up in a range of related areas, including agriculture, diagnostics, carbon and methane upcycling, and cancer therapeutics, check out what the nine teams have been working on.

    Some of IndieBio’s previous breakout startups include the cultivated meat company Upside Foods (it raised $400 million last year led by two sovereign wealth funds at a billion-dollar-plus valuation) and MycoWorks, a company making leather out of fungi and that closed a $125 million Series C round last year at an undisclosed valuation. Another company in IndieBio’s portfolio to gain traction is NotCo, an outfit now also backed by Jeff Bezos and Kraft Heinz that licenses its tech to food and beverage manufacturers that want to “veganize” some of their products.

    Here’s a quick snapshot of each:

    FREZENT Biological Solutions

    FREZENT says it’s developing a novel class of bispecific antibodies for targeting dormant cancer cells that have survived chemotherapy and may cause recurrence. Its approach is to block metabolism in dormant cancer cells to prevent their reactivation and survival. The team is currently focused on monoclonal antibody discovery and proof-of-concept studies. More here.

    ***Techcrunch event

    Join 10k+ tech and VC leaders for growth and connections at Disrupt 2025

    Netflix, Box, a16z, ElevenLabs, Wayve, Sequoia Capital, Elad Gil — just some of the 250+ heavy hitters leading 200+ sessions designed to deliver the insights that fuel startup growth and sharpen your edge. Don’t miss the 20th anniversary of TechCrunch, and a chance to learn from the top voices in tech. Grab your ticket before Sept 26 to save up to $668.

    Join 10k+ tech and VC leaders for growth and connections at Disrupt 2025

    Netflix, Box, a16z, ElevenLabs, Wayve, Sequoia Capital, Elad Gil — just some of the 250+ heavy hitters leading 200+ sessions designed to deliver the insights that fuel startup growth and sharpen your edge. Don’t miss the 20th anniversary of TechCrunch, and a chance to learn from the top voices in tech. Grab your ticket before Sept 26 to save up to $668.

    San Francisco | October 27-29, 2025 REGISTER NOW

    Xias Bio Limited

    According to Xias Bio, the three most important proteins in skincare and haircare products — collagen, keratin and elastin — typically come from bovine hides, chicken feathers and meat processing byproducts (blech). Given rising concerns over greenhouse gas emissions, water pollution and deforestation, a new generation of cosmetics consumers wants to see the industry replace those animal proteins with sustainable alternatives, and Xias Bio is catering to them. Specifically, it has developed a molecular platform for creating multi-functional, animal-free proteins to license. L’Oréal is already buying what it’s selling; later, say the startup’s founders, the idea is to move beyond cosmetics and replace animal proteins in a host of other areas, including in pharmaceuticals and the food industry.

    ***

    Earnest Agriculture

    Earnest Agriculture says it has designed a microbial consortium that protects crops against diseases, pests and drought while improving soil health. Applied as a seed coating, those patented microbes can boost yields by 7x, reduce synthetic chemical use and make crops more resilient to climate change, claims the outfit. More here.

    ***

    BioMetallica

    BioMetallica’s pitch is that tens of millions of tons of electronics are discarded every year, much of it incinerated, with billions of dollars of recoverable materials up in smoke in the process — not to mention the release of toxic fumes. The startup’s eco-friendly solution for recovering some of these rare metals — palladium, platinum and rhodium — is through genetically modified bacteria that produce biogenic chemicals that separate palladium group metals (PMGs) from e-waste, including spent catalytic converters.

    ***

    Afynia

    Afynia has created and patented a blood test for diagnosing endometriosis early that returns a result in days and — says the startup — will be offered through clinics and home collection kits beginning next year.  As with many women’s health startups, the team’s endometriosis test is just the beginning, if all goes as planned. The idea is to build a digital platform that will provide diagnostics, virtual care and prescription deliveries for endometriosis and other conditions. More here (note that the startup was originally named AIMA and hasn’t refreshed its site just yet).

    ***

    Carbon Bridge

    To meet EU emissions standards, cargo operators are already ordering methanol-powered ships, but green methanol can’t compete with oil on price, meaning adoption is slow going. CarbonBridge‘s solution to the challenge is what it describes as a low-heat, low-pressure microbial process that upcycles carbon dioxide and methane into liquid methanol using a bioreactor. More, it says, it can source the gasses inexpensively from over 16,000 wastewater treatment facilities in the U.S. that normally burn them off.

    ***

    Aequor

    Aequor says it has discovered marine microbes that produce molecules that eliminate bacterial slime in minutes, and that applied in water treatment facilities, its liquid concentrate can reduce conventional chemical usage by 90%, lower energy usage by up to 15% and prevent slime from clogging filters and causing shutdowns. The bigger ambition is to reduce the costs and environmental impact of water treatment while enabling greater access to safe, affordable drinking water. More here.

    ***

    Unibaio

    Farmers spend nearly $230 billion every year on herbicides, pesticides and fertilizers designed to increase crop yields, but the unintended consequences are well-documented and, well, not good. Unibaio says it has a better alternative. According to the company, it has developed a natural microparticle that can supercharge biological crop protectants by enabling them to penetrate plants more efficiently and reduce the amount of conventional chemical products needed by up to 80%.

    ***

    Terra Bioindustries

    Discarded food accounts for 8-10% of greenhouse gas emissions, as the founders of Terra Bioindustries will tell you; it’s why the company developed a platform for upcycling brewers’ spent grain, a beer byproduct that is apparently often difficult to sell. It works via a low-energy enzymatic process that separates the grain into edible sugars and proteins that are then sold to food manufacturers and precision fermentation companies. By using commercial equipment found in most food processing facilities, adoption can be inexpensive, too, says the outfit. More here.

    • 上一篇:The changing cloud landscape: From observability to optimization
    • 下一篇:Uber and Motional to launch robotaxis across US over 10 years

      相关文章

      • Track and capture: Getting started with attention metrics
      • AudiencePlus wants to help every company run its own media platform
      • Daily Crunch: Meta is dismissing around 4,000 more employees this week 
      • 3 days left until Disrupt prices increase
      • Integration platform Cinchy lands fresh cash to connect data sources
      • Quilt raises $9M seed round to become the Nest of heat pumps
      • Vote for the roundtables and breakouts you want at Disrupt
      • Accounting automation startup Trullion lands $15M investment
      • Flora poised to bloom as sustainable brand marketplace launches this year
      • Hidden in plain sight: 5 red flags for investors

        随便看看

      • Neoplants bioengineers houseplants to use them as air purifiers
      • Antimetal is putting AI to work to root out cloud cost inefficiencies
      • Register now to attend today's filming of TechCrunch Live with ClassDojo and SignalFire
      • Fiverr Enterprise aims to streamline managing large groups of freelancers
      • Dear Sophie: How should I prepare for my visa interview?
      • Augmental lets you control a computer (and sex toys) with your tongue
      • TC Disrupt 2023 Call for Content ends tomorrow
      • Citymapper lowers the paywall for premium features but keeps monthly subscription for removing ads
      • Daily Crunch: Say 'fromage'! French startup PhotoRoom captures $19M Series A
      • Daily Crunch: IBM says its new watsonx platform is an 'enterprise studio for AI builders'
      • Copyright © 2025 Powered by 【】,都市天下脉观察   辽ICP备198741324484号sitemap